Tyra Biosciences, Inc.TYRANASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+69.8%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+69.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
20256.05+160.9%
20242.32-20.0%
20232.90+134.5%
20221.23-36.1%
20211.93+102.4%
2020-81.09+65.2%
2019-233.27-